Nanexa AB
- Biotech or pharma, therapeutic R&D
- Biotech or pharma, animal health
- Medical device or technology
Nanexa is a drug development company focused on Long Acting Injectables (LAIs) utilizing our innovative PharmaShell® drug delivery system. The company has demonstrated positive Phase 1 results for NEX-22, a long-acting formulation of liraglutide for type 2 diabetes. PharmaShell® is a high drug load delivery system enabling the next generation long-acting injectables by atomic layer precision
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}